• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评价溶酶体酸性脂肪酶缺乏症患者的生化特征以及脂质和蛋白质的氧化损伤。

Evaluation of biochemical profile and oxidative damage to lipids and proteins in patients with lysosomal acid lipase deficiency.

机构信息

Faculdade de Farmácia, UFRGS, Porto Alegre 90610-000, RS, Brasil.

Serviço de Genética Médica, HCPA, UFRGS, Rua Ramiro Barcelos, Porto Alegre, 90035-903, RS, Brasil.

出版信息

Biochem Cell Biol. 2023 Aug 1;101(4):294-302. doi: 10.1139/bcb-2022-0330. Epub 2023 Apr 12.

DOI:10.1139/bcb-2022-0330
PMID:37042460
Abstract

Lysosomal acid lipase deficiency (LALD) is an inborn error of metabolism that lacks satisfactory treatment, which leads to the development of severe hepatic and cardiac complications and may even lead to death. In this sense, knowledge of the mechanisms involved in the pathophysiology of this disorder becomes essential to allow the search for new therapeutic strategies. There are no studies in the literature investigating the role of reactive species and inflammatory processes in the pathophysiology of this disorder. Therefore, the aim of this work was to investigate parameters of oxidative and inflammatory stress in LALD patients. In this work, we obtained results that demonstrate that LALD patients are susceptible to oxidative stress caused by an increase in the production of free radicals, observed by the increase of 2-7-dihydrodichlorofluorescein. The decrease in sulfhydryl content reflects oxidative damage to proteins, as well as a decrease in antioxidant defenses. Likewise, the increase in urinary levels of di-tyrosine observed also demonstrates oxidative damage to proteins. Furthermore, the determination of chitotriosidase activity in the plasma of patients with LALD was significantly higher, suggesting a pro-inflammatory state. An increase in plasma oxysterol levels was observed in patients with LALD, indicating an important relationship between this disease and cholesterol metabolism and oxidative stress. Also, we observed in LALD patients increased levels of nitrate production. The positive correlation found between oxysterol levels and activity of chitotriosidase in these patients indicates a possible link between the production of reactive species and inflammation. In addition, an increase in lipid profile biomarkers such as total and low-density lipoprotein cholesterol were demonstrated in the patients, which reinforces the involvement of cholesterol metabolism. Thus, we can assume that, in LALD, oxidative and nitrosative damage, in addition to inflammatory process, play an important role in its evolution and future clinical manifestations. In this way, we can suggest that the study of the potential benefit of the use of antioxidant and anti-inflammatory substances as an adjuvant tool in the treatment will be important, which should be associated with the already recommended therapy.

摘要

溶酶体酸性脂肪酶缺乏症(LALD)是一种代谢性先天缺陷,缺乏令人满意的治疗方法,这会导致严重的肝和心脏并发症,甚至可能导致死亡。从这个意义上说,了解这种疾病病理生理学中涉及的机制对于寻找新的治疗策略变得至关重要。目前,文献中没有研究活性氧物质和炎症过程在这种疾病病理生理学中的作用。因此,本工作的目的是研究 LALD 患者氧化和炎症应激的参数。在这项工作中,我们获得的结果表明,LALD 患者易受到自由基产生增加引起的氧化应激的影响,这可以通过二氢二氯荧光素的增加来观察到。巯基含量的减少反映了蛋白质的氧化损伤,以及抗氧化防御的减少。同样,观察到尿中二酪氨酸水平的增加也表明了蛋白质的氧化损伤。此外,LALD 患者血浆中几丁质酶活性的测定显著升高,表明存在炎症前状态。在 LALD 患者中观察到血浆氧化固醇水平升高,表明该疾病与胆固醇代谢和氧化应激之间存在重要关系。此外,我们在 LALD 患者中观察到硝酸盐产生水平增加。在这些患者中发现的氧化固醇水平与几丁质酶活性之间的正相关表明,活性物质的产生和炎症之间可能存在联系。此外,在患者中证明了脂质谱生物标志物(如总胆固醇和低密度脂蛋白胆固醇)的增加,这加强了胆固醇代谢的参与。因此,我们可以假设,在 LALD 中,氧化和硝化损伤以及炎症过程在其演变和未来临床表现中起着重要作用。因此,我们可以建议,研究使用抗氧化和抗炎物质作为辅助治疗工具的潜在益处将是重要的,这应与已建议的治疗相结合。

相似文献

1
Evaluation of biochemical profile and oxidative damage to lipids and proteins in patients with lysosomal acid lipase deficiency.评价溶酶体酸性脂肪酶缺乏症患者的生化特征以及脂质和蛋白质的氧化损伤。
Biochem Cell Biol. 2023 Aug 1;101(4):294-302. doi: 10.1139/bcb-2022-0330. Epub 2023 Apr 12.
2
Clinical outcome of a patient with lysosomal acid lipase deficiency and first results after initiation of treatment with Sebelipase alfa: A case report.一名溶酶体酸性脂肪酶缺乏症患者的临床结局及开始使用阿糖苷酶α治疗后的初步结果:病例报告
Mol Genet Metab Rep. 2019 Jun 18;20:100479. doi: 10.1016/j.ymgmr.2019.100479. eCollection 2019 Sep.
3
Inflammatory process and oxidative/nitrative stress: in vivo study in mucopolysaccharidosis type IV A patients under long-term enzyme replacement therapy.炎症过程与氧化/硝化应激:长期酶替代疗法治疗IV A型黏多糖贮积症患者的体内研究
Arch Biochem Biophys. 2023 Mar 15;737:109541. doi: 10.1016/j.abb.2023.109541. Epub 2023 Feb 6.
4
Evaluation of two approaches to lysosomal acid lipase deficiency patient identification: An observational retrospective study.两种溶酶体酸性脂肪酶缺乏症患者识别方法的评估:一项观察性回顾性研究。
Atherosclerosis. 2019 Jun;285:49-54. doi: 10.1016/j.atherosclerosis.2019.03.013. Epub 2019 Mar 18.
5
Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease-four new pediatric cases.儿童期/成人期起病的溶酶体酸性脂肪酶缺乏症:一种超越肝脏疾病的严重代谢和血管表型——4例新的儿科病例
J Clin Lipidol. 2017 Jan-Feb;11(1):167-177.e3. doi: 10.1016/j.jacl.2016.11.008. Epub 2016 Dec 6.
6
Persistent dyslipidemia in treatment of lysosomal acid lipase deficiency.溶酶体酸性脂肪酶缺乏症治疗中持续性血脂异常。
Orphanet J Rare Dis. 2020 Feb 24;15(1):58. doi: 10.1186/s13023-020-1328-6.
7
The role of sebelipase alfa in the treatment of lysosomal acid lipase deficiency.塞贝利普酶α在治疗溶酶体酸性脂肪酶缺乏症中的作用。
Therap Adv Gastroenterol. 2017 Jul;10(7):553-562. doi: 10.1177/1756283X17705775. Epub 2017 Apr 26.
8
Update on lysosomal acid lipase deficiency: Diagnosis, treatment and patient management.溶酶体酸性脂肪酶缺乏症的最新进展:诊断、治疗及患者管理
Med Clin (Barc). 2017 May 10;148(9):429.e1-429.e10. doi: 10.1016/j.medcli.2016.12.044. Epub 2017 Mar 9.
9
Lysosomal acid lipase deficiency: A hidden disease among cohorts of familial hypercholesterolemia?溶酶体酸性脂肪酶缺乏症:家族性高胆固醇血症群体中的一种隐匿疾病?
J Clin Lipidol. 2017 Mar-Apr;11(2):477-484.e2. doi: 10.1016/j.jacl.2016.11.002. Epub 2016 Nov 17.
10
Urinary biomarkers of oxidative stress and plasmatic inflammatory profile in phenylketonuric treated patients.苯丙酮尿症治疗患者氧化应激的尿液生物标志物及血浆炎症指标
Int J Dev Neurosci. 2015 Dec;47(Pt B):259-65. doi: 10.1016/j.ijdevneu.2015.10.001. Epub 2015 Oct 8.

引用本文的文献

1
Practical Recommendations for the Diagnosis and Management of Lysosomal Acid Lipase Deficiency with a Focus on Wolman Disease.以沃尔曼病为重点的溶酶体酸性脂肪酶缺乏症诊断与管理实用建议
Nutrients. 2024 Dec 13;16(24):4309. doi: 10.3390/nu16244309.